Literature DB >> 22675663

Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Jeffrey D Lifson1, Nancy L Haigwood.   

Abstract

Nonhuman primate (NHP) disease models for AIDS have made important contributions to the search for effective vaccines for AIDS. Viral diversity, persistence, capacity for immune evasion, and safety considerations have limited development of conventional approaches using killed or attenuated vaccines, necessitating the development of novel approaches. Here we highlight the knowledge gained and lessons learned in testing vaccine concepts in different virus/NHP host combinations.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22675663      PMCID： PMC3367532          DOI： 10.1101/cshperspect.a007310

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN： 2157-1422            Impact factor:   6.915


  170 in total

1.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

3.  Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.

Authors:  P L Earl; W Sugiura; D C Montefiori; C C Broder; S A Lee; C Wild; J Lifson; B Moss
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody.

Authors:  M C Gauduin; J T Safrit; R Weir; M S Fung; R A Koup
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

5.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

6.  Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.

Authors:  Richard A Koup; Mario Roederer; Laurie Lamoreaux; Jennifer Fischer; Laura Novik; Martha C Nason; Brenda D Larkin; Mary E Enama; Julie E Ledgerwood; Robert T Bailer; John R Mascola; Gary J Nabel; Barney S Graham
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

7.  Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous Simian Immunodeficiency Virus-specific CD8(+) T cell clones during acute and chronic infection of rhesus macaques.

Authors:  Diane L Bolton; Jacob T Minang; Matthew T Trivett; Kaimei Song; Jennifer J Tuscher; Yuan Li; Michael Piatak; David O'Connor; Jeffrey D Lifson; Mario Roederer; Claes Ohlen
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

8.  Simian immunodeficiency virus SIVrcm, a unique CCR2-tropic virus, selectively depletes memory CD4+ T cells in pigtailed macaques through expanded coreceptor usage in vivo.

Authors:  Rajeev Gautam; Thaidra Gaufin; Isolde Butler; Aarti Gautam; Mary Barnes; Daniel Mandell; Melissa Pattison; Coty Tatum; Jeanne Macfarland; Christopher Monjure; Preston A Marx; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

9.  Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.

Authors:  L D Giavedoni; V Planelles; N L Haigwood; S Ahmad; J D Kluge; M L Marthas; M B Gardner; P A Luciw; T D Yilma
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

Review 10.  HIV-1 Vif, APOBEC, and intrinsic immunity.

Authors:  Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2008-06-24       Impact factor: 4.602
View more
  38 in total

Review 1.  Host genes important to HIV replication and evolution.

Authors:  Amalio Telenti; Welkin E Johnson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 2.  The Antibody Response against HIV-1.

Authors:  Julie Overbaugh; Lynn Morris
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.

Authors:  Tara R Henning; Katherine Butler; Debra Hanson; Gail Sturdevant; Shanon Ellis; Elizabeth M Sweeney; James Mitchell; Frank Deyounks; Christi Phillips; Carol Farshy; Yetunde Fakile; John Papp; W Evan Secor; Harlan Caldwell; Dorothy Patton; Janet M McNicholl; Ellen Kersh
Journal:  J Infect Dis       Date:  2014-04-21       Impact factor: 5.226

Review 4.  Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.

Authors:  George K Lewis; Anthony L DeVico; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

5.  Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies.

Authors:  Gregory Q Del Prete; Matthew Scarlotta; Laura Newman; Carolyn Reid; Laura M Parodi; James D Roser; Kelli Oswald; Preston A Marx; Christopher J Miller; Ronald C Desrosiers; Dan H Barouch; Ranajit Pal; Michael Piatak; Elena Chertova; Luis D Giavedoni; David H O'Connor; Jeffrey D Lifson; Brandon F Keele
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

6.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  Escherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection.

Authors:  Lin-Xu Wang; Michael Mellon; Dane Bowder; Meghan Quinn; Danielle Shea; Charles Wood; Shi-Hua Xiang
Journal:  Virology       Date:  2014-12-05       Impact factor: 3.616

8.  Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising.

Authors:  Shishi Luo; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 9.  Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues.

Authors:  Jacob D Estes
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors.

Authors:  Masako Nomaguchi; Masaru Yokoyama; Ken Kono; Emi E Nakayama; Tatsuo Shioda; Naoya Doi; Sachi Fujiwara; Akatsuki Saito; Hirofumi Akari; Kei Miyakawa; Akihide Ryo; Hirotaka Ode; Yasumasa Iwatani; Tomoyuki Miura; Tatsuhiko Igarashi; Hironori Sato; Akio Adachi
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.